Skip to main content
Guerbet logo

Guerbet — Investor Relations & Filings

Ticker · GBT ISIN · FR0000032526 LEI · 969500WV1U1WQ059L135 PA Manufacturing
Open in API
Filings indexed 623 across all filing types
Latest filing 2024-07-23 Declaration of Voting R…
Country FR France
Listing PA GBT

About Guerbet

https://www.guerbet.com

Guerbet is a global specialist in medical imaging, offering a comprehensive range of solutions and services for diagnostic and interventional procedures. The company develops and manufactures contrast media, medical devices such as injectors, and related software for X-ray, Magnetic Resonance Imaging (MRI), and Interventional Imaging. With a history of innovation dating back to 1926, Guerbet focuses on providing healthcare professionals with tools to enhance diagnostic accuracy and improve patient care. Its portfolio is designed to support a wide array of clinical applications, from initial diagnosis to treatment monitoring.

Recent filings

Filing Released Lang Actions
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 30 juin 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a press release dated July 23, 2024, titled "DECLARATION RELATIVE AU NOMBRE DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL DE LA SOCIETE" (Declaration relative to the number of voting rights and shares comprising the capital of the company). It explicitly states it is published in application of French commercial code articles requiring monthly publication of the total number of voting rights and shares, especially when they have varied. The content is a table detailing the total shares, treasury shares, and total/exercisable voting rights as of June 30, 2024. This directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA), which covers official results from shareholder votes or, as in this case, mandatory periodic disclosures regarding voting rights structure.
2024-07-23 French
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 mai 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a press release dated June 24, 2024, titled "DECLARATION RELATIVE AU NOMBRE DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL DE LA SOCIETE" (Declaration relating to the number of voting rights and shares comprising the capital of the company). It explicitly states it is published in application of French commercial code (L. 233-8 II) and AMF regulations (article 222-12-5) to report the total number of voting rights and shares at the end of the month (May 31, 2024). This content directly corresponds to the definition of Declaration of Voting Results & Voting Rights Announcements (DVA), which covers official results from shareholder votes or related statutory disclosures on voting rights.
2024-06-24 French
Guerbet : Hugues Lecat nommé Président du Conseil d’administration de Guerbet.
Board/Management Information Classification · 99% confidence The document announces the appointment of Hugues Lecat as Chairman of the Board of Directors ('Président du Conseil d'administration') of Guerbet, following approval by the general assembly. This concerns changes in the company's board of directors and senior management structure. This directly aligns with the definition for Board/Management Information (MANG). The document is a press release detailing management changes, not a formal regulatory filing like a 10-K or an earnings release.
2024-05-24 French
Guerbet : Hugues Lecat appointed Chairman of the Board of Directors of Guerbet.
Board/Management Information Classification · 100% confidence The document explicitly announces the appointment of Hugues Lecat as Chairman of the Board of Directors following approval at the Annual General Meeting (AGM) held on the same day. This content directly relates to changes in the company's board structure and senior management. While it mentions the AGM, the core subject is the management change, making 'Board/Management Information' (MANG) the most appropriate primary classification. It is not a full AGM presentation (AGM-R) or a general governance report (CGR), but a specific announcement about a key leadership change.
2024-05-24 English
Guerbet : NUCLIDIUM and Guerbet Form Strategic Partnership to Support the Advancement of targeted Copper-based Radiotheranostics.
Regulatory Filings Classification · 95% confidence The document announces a strategic partnership between NUCLIDIUM and Guerbet regarding radiotheranostics development. It details the terms, including a strategic investment by Guerbet and a board observer seat. This type of announcement, detailing corporate agreements, investments, and strategic collaborations, does not fit the definitions for standard financial reports (10-K, IR, ER), shareholder actions (AGM-R, DVA), or management changes (MANG). It is a corporate development announcement. Since there is no specific category for 'Strategic Partnership Announcement,' and it involves a corporate agreement and investment, it is best classified as a general Regulatory Filing (RNS) or potentially a Capital/Financing Update (CAP) due to the investment component. However, the primary focus is the strategic collaboration, making RNS the most appropriate general regulatory/corporate announcement fallback, as it is not a formal SEC filing type listed (like 10-K or DEF 14A). Given the options, RNS serves as the best fit for a non-standard corporate press release detailing a business agreement.
2024-05-22 English
Guerbet : NUCLIDIUM et Guerbet concluent un partenariat stratégique pour soutenir le développement de la radiothéranostique ciblée basée sur des radio-isotopes de cuivre.
Regulatory Filings Classification · 95% confidence The document is titled "COMMUNIQUE DE PRESSE" (Press Release) and announces a strategic partnership between NUCLIDIUM and Guerbet regarding radiotheranostics. It details the terms (strategic investment, board observer seat) and the strategic rationale for both companies. This type of announcement, detailing a significant business development, partnership, or corporate event that is not a mandatory periodic financial filing (like 10-K or IR), typically falls under general corporate news or regulatory announcements. Since it is a formal press release announcing a major business agreement, it is best classified as a general Regulatory Filing (RNS) as it serves as a public disclosure, although it is not a specific financial report type listed. It is too detailed for a simple Report Publication Announcement (RPA) and does not fit any other specific category like M&A (TAR), Capital Change (CAP), or Earnings Release (ER).
2024-05-22 French

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.